Howard Marks (Oaktree Capital) other BioXcel Therapeutics, Inc.
Howard Marks (Oaktree Capital) other $436.6K of disclosed value in BioXcel Therapeutics, Inc..
Signal
Investor Move
Action
Other
Capital
$436.6K disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.